#Sample Identifier	Patient Identifier	Cancer Type	Diagnosis Age	Person Gender	Prior Treatment	Epithelial	Tumor Other Histologic Subtype	Sample Type	Ploidy	P53	MDR	Doubling Time	Cancer Type Detailed
#A unique sample identifier.	Identifier to uniquely specify a patient.	Disease type	Age at which a condition or disease was first diagnosed.	Patient gender.	Prior treatment.	Epithelial.	Text to describe a tumor's histologic subtype or mixed diagnosis that is different from previously specified options.	The type of sample (i.e., normal, primary, met, recurrence).	Ploidy.	P53.	MDR.	Doubling time.	Cancer Type Detailed
#STRING	STRING	STRING	NUMBER	STRING	STRING	STRING	STRING	STRING	NUMBER	STRING	NUMBER	NUMBER	STRING
#SAMPLE	PATIENT	SAMPLE	PATIENT	PATIENT	PATIENT	SAMPLE	PATIENT	SAMPLE	SAMPLE	SAMPLE	SAMPLE	SAMPLE	SAMPLE
#1	1	1	1	1	1	1	1	1	1	1	1	1	1
SAMPLE_ID	PATIENT_ID	CANCER_TYPE	AGE	GENDER	PRIOR_TREATMENT	EPITHELIAL	HISTOLOGICAL_SUBTYPE	SAMPLE_TYPE	PLOIDY	P53	MDR	DOUBLING_TIME	CANCER_TYPE_DETAILED
BT_549	BT_549	Breast Sarcoma	72	F	NA	yes	Papillary infiltrating ductal carcinoma-mammary gland; breast	Metastasis	3n+/-, Near-triploid 69+/- (58-80)	?	-45	53.9	Breast
HS578T	HS578T	Breast Sarcoma	74	F	NA	yes	Carcinosarcoma-mammary gland; breast	Primary	2n+, Hyperdiploid (47-57)	MT	NA	53.8	Breast
MCF7	MCF7	Breast Sarcoma	69	F	NA	yes	Adenocarcinoma- mammary gland; breast; metastatic site: pleural effusion;	Pleural effusion	3n-, Hypotriploid (58-68)	WT	14	25.4	Breast
MDA_MB_231	MDA_MB_231	Breast Sarcoma	51	F	NA	yes	Adenocarcinoma-mammary gland; breast; epithelial; metastatic site: pleural effusion;	Pleural effusion	2n+, Hyperdiploid (47-57)	MT	29	41.9	Breast
T47D	T47D	Breast Sarcoma	54	F	NA	yes	infiltrating ductal carcinoma	NA	2n+, Hyperdiploid (47-57)	MT	19	45.5	Breast
SF_268	SF_268	Cancer of Unknown Primary	24	F	Rad	no	Glioblastoma, ud	NA	2n+, Hyperdiploid (47-57)	MT	-38	33.1	Mixed Cancer Types
SF_295	SF_295	Cancer of Unknown Primary	67	F	Rad	no	Glioblastoma, ud	NA	5n+/-, Near-pentaploid 115+/- (104-126)	MT	91	29.5	Mixed Cancer Types
SF_539	SF_539	Cancer of Unknown Primary	34	F	Rad/BCNU/5FU/HU/6MP	no	Glial cell neoplasm	NA	4n+/-, Near-tetraploid 92+/- (81-103)	WT	-40	35.4	Mixed Cancer Types
SNB_19	SNB_19	Cancer of Unknown Primary	47	M	None	no	Glioblastoma, ud	NA	3n+/-, Near-triploid 69+/- (58-80)	MT	-41	34.6	Mixed Cancer Types
SNB_75	SNB_75	Cancer of Unknown Primary	NA	F	None	no	Astrocytoma	NA	2n+, Hyperdiploid (47-57)	MT	-38	62.8	Mixed Cancer Types
U251	U251	Cancer of Unknown Primary	75	M	NA	no	Glioblastoma,ud	NA	2n+, Hyperdiploid (47-57)	MT	-19	23.8	Mixed Cancer Types
COLO205	COLO205	Cancer of Unknown Primary	70	M	NA	yes	Adenocarcinoma	Ascites	3n, Triploid (69)	MT	7	23.8	Mixed Cancer Types
HCC_2998	HCC_2998	Cancer of Unknown Primary	NA	NA	NA	yes	carcinoma	NA	2n+/-, Near-diploid 46+/- (35-57)	MT	-5	31.5	Mixed Cancer Types
HCT_116	HCT_116	Cancer of Unknown Primary	NA	M	NA	yes	carcinoma-vpd	NA	2n-, Hypodiploid (35-45)	?	26	17.4	Mixed Cancer Types
HCT_15	HCT_15	Cancer of Unknown Primary	NA	NA	None	yes	Adenocarcinoma p/md	NA	2n+/-, Near-diploid 46+/- (35-57)	?	414	20.6	Mixed Cancer Types
HT29	HT29	Cancer of Unknown Primary	44	F	None	yes	Adenocarcinoma-md	Primary	3n+/-, Near-triploid 69+/- (58-80)	MT	15	19.5	Mixed Cancer Types
KM12	KM12	Cancer of Unknown Primary	NA	NA	None	yes	Adenocarcinome-pd	NA	2n+/-, Near-diploid 46+/- (35-57)	MT	-19	23.7	Mixed Cancer Types
SW_620	SW_620	Cancer of Unknown Primary	51	M	NA	yes	Carcinoma-ud	NA	2n+/-, Near-diploid 46+/- (35-57)	MT	31	20.4	Mixed Cancer Types
A549	A549	Cancer of Unknown Primary	58	M	NA	yes	Adenocarcinoma-p/md	NA	3n+/-, Near-triploid 69+/- (58-80)	WT	10	22.9	Mixed Cancer Types
EKVX	EKVX	Cancer of Unknown Primary	NA	M	NA	yes	Adenocarcinoma-md	NA	3n+/-, Near-triploid 69+/- (58-80)	MT	-9	43.6	Mixed Cancer Types
HOP_62	HOP_62	Cancer of Unknown Primary	60	F	None	yes	adenocarcinoma-ud	NA	4n+, Hypertetraploid (93-103)	MT	61	39	Mixed Cancer Types
HOP_92	HOP_92	Cancer of Unknown Primary	62	M	None	yes	Large cell-ud	NA	4n+/-, Near-tetraploid 92+/- (81-103)	MT	-4	79.5	Mixed Cancer Types
NCI_H226	NCI_H226	Cancer of Unknown Primary	NA	M	None (non smoker)	yes	Squamous cell carcinoma-vpd	NA	3n, Triploid (69)	MT	7	61	Mixed Cancer Types
NCI_H23	NCI_H23	Cancer of Unknown Primary	NA	M	None	yes	Adenocarcinoma-ud	NA	2n+, Hyperdiploid (47-57)	MT	-2	33.4	Mixed Cancer Types
NCI_H322M	NCI_H322M	Cancer of Unknown Primary	52	M	None	yes	Small cell Bronchioalveolar Carcinoma	NA	2n+/-, Near-diploid 46+/- (35-57)	MT	-10	35.3	Mixed Cancer Types
NCI_H460	NCI_H460	Cancer of Unknown Primary	NA	M	NA	yes	Large Cell Carcinoma-ud	Pleural effusion	2n+/-, Near-diploid 46+/- (35-57)	WT	25	17.8	Mixed Cancer Types
NCI_H522	NCI_H522	Cancer of Unknown Primary	NA	M	None	yes	Adenocarcinoma-vpd	NA	2n+/-, Near-diploid 46+/- (35-57)	MT	16	38.2	Mixed Cancer Types
CCRF_CEM	CCRF_CEM	Leukemia	4	F	Rad/Mtx/Cyx	no	ALL	NA	2n+/-, Near-diploid 46+/- (35-57)	MT	35	26.7	Leukemia
HL_60	HL_60	Leukemia	36	M	None	no	Pro myelocytic leukemia	PBL	2n+/-, Near-diploid 46+/- (35-57)	MT	-11	28.6	Leukemia
K_562	K_562	Leukemia	53	F	Bisulfan/PiBr	no	CML	Pleural effusion	3n-, Hypotriploid (58-68)	MT	-1	19.6	Leukemia
MOLT_4	MOLT_4	Leukemia	19	M	VB/6MP/Pred	no	ALL (cells were taken when patient was in relapse)	PB	4n, Tetraploid (92)	WT	10	27.9	Leukemia
RPMI_8226	RPMI_8226	Leukemia	61	M	None	no	Myeloma	PB	3n-, Hypotriploid (58-68)	WT	-3	33.5	Leukemia
SR	SR	Leukemia	11	M	Y	no	Lymphoma	NA	2n+/-, Near-diploid 46+/- (35-57)	?	4	28.7	Leukemia
LOXIMVI	LOXIMVI	Melanoma	58	M	None	no	Malignant amelanotic melanoma	NA	3n+/-, Near-triploid 69+/- (58-80)	WT	12	20.5	Melanoma
M14	M14	Melanoma	NA	NA	NA	no	Melanotic melanoma	NA	3n+/-, Near-triploid 69+/- (58-80)	MT	14	26.3	Melanoma
MALME_3M	MALME_3M	Melanoma	43	M	None	no	Malignant melanotic melanoma	Metastasis	4n+/-, Near-tetraploid 92+/- (81-103)	WT	22	46.2	Melanoma
MDA_MB_435	MDA_MB_435	Melanoma	31	F	NA	no	Ductal carcinoma- mammary gland; breast; duct; metastatic site: pleural effusion;	Pleural effusion	2n+, Hyperdiploid (47-57)	MT	20	25.8	Melanoma
MDA_N	MDA_N	Melanoma	31	F	NA	no	Ductal carcinoma- mammary gland; breast; duct; metastatic site: pleural effusion;	Pleural effusion	NA	MT	12	22.5	Melanoma
SK_MEL_2	SK_MEL_2	Melanoma	60	M	None	no	Malignant melanotic melanoma	Metastasis	4n-, Hypotetraploid (81-91)	WT	14	45.5	Melanoma
SK_MEL_28	SK_MEL_28	Melanoma	51	M	None	no	Malignant melanotic melanoma	NA	4n-, Hypotetraploid (81-91)	MT	11	35.1	Melanoma
SK_MEL_5	SK_MEL_5	Melanoma	24	F	None	no	Malignant melanotic melanoma	Metastasis	4n+, Hypertetraploid (93-103)	WT	12	25.2	Melanoma
UACC_257	UACC_257	Melanoma	NA	NA	NA	no	Melanotic melanoma	NA	3n+, Hypertriploid (70-80)	WT	26	38.5	Melanoma
UACC_62	UACC_62	Melanoma	NA	NA	NA	no	Melanotic melanoma	NA	3n+/-, Near-triploid 69+/- (58-80)	WT	8	31.3	Melanoma
IGROV1	IGROV1	Cancer of Unknown Primary	47	F	Rad	yes	Cystoadenocarcinoma-pd	NA	4n+/-, Near-tetraploid 92+/- (81-103)	MT	20	31	Mixed Cancer Types
NCI_ADR_RES	NCI_ADR_RES	Cancer of Unknown Primary	NA	F	NA	yes	Adenocarinoma	NA	2n+/-, Near-diploid 46+/- (35-57)	MT	352	34	Mixed Cancer Types
OVCAR_3	OVCAR_3	Cancer of Unknown Primary	60	F	CyPh/CsPt/Adr	yes	Adenocarcinoma-md	Ascites	3n+/-, Near-triploid 69+/- (58-80)	MT	-12	34.7	Mixed Cancer Types
OVCAR_4	OVCAR_4	Cancer of Unknown Primary	42	F	CyPh/CsPt/Adr	yes	Adenocarcinoma-md	NA	3n+/-, Near-triploid 69+/- (58-80)	WT	-4	41.4	Mixed Cancer Types
OVCAR_5	OVCAR_5	Cancer of Unknown Primary	67	F	None	yes	Adenocarcinoma-wd	NA	2n+, Hyperdiploid (47-57)	MT	13	48.8	Mixed Cancer Types
OVCAR_8	OVCAR_8	Cancer of Unknown Primary	64	F	Ctx/Adr/CsPt/CyPh	yes	Carcinoma-ud	NA	2n+, Hyperdiploid (47-57)	MT	7	26.1	Mixed Cancer Types
SK_OV_3	SK_OV_3	Cancer of Unknown Primary	64	F	Thiotepa	yes	Adenocarcinoma-vpd	Ascites	4n+/-, Near-tetraploid 92+/- (81-103)	?	15	48.7	Mixed Cancer Types
DU_145	DU_145	Prostate Cancer	69	M	Androgen independent and unresposive to hormone therapy	yes	prostate; metastatic site: brain; carcinoma (patient with metastatic carcinoma of the prostate and a 3 year history of lymphocytic leukemia.)	Metastasis	3n+/-, Near-triploid 69+/- (58-80)	?	4	32.3	Prostate
PC_3	PC_3	Prostate Cancer	62	M	NA	yes	Adenocarcinoma- prostate; metastatic site: bone;	NA	4n, Tetraploid (92)	MT	11	27.1	Prostate
786_0	786_0	Cancer of Unknown Primary	58	M	None	yes	Adenocarcinoma	NA	4n+/-, Near-tetraploid 92+/- (81-103)	MT	-44	22.4	Mixed Cancer Types
A498	A498	Cancer of Unknown Primary	52	M	NA	yes	Adenocarcinoma	NA	3n, Triploid (69)	WT	78	66.8	Mixed Cancer Types
ACHN	ACHN	Cancer of Unknown Primary	22	M	Rad/VB/CCNU/Mto/Pred	yes	Renal cell carcinoma-p/md	NA	2n+/-, Near-diploid 46+/- (35-57)	WT	120	27.5	Mixed Cancer Types
CAKI_1	CAKI_1	Cancer of Unknown Primary	49	M	Rad/HU/5FU/Mtx/Ctx	yes	Clear cell carcinoma	Metastasis	3n, Triploid (69)	WT	171	39	Mixed Cancer Types
RXF_393	RXF_393	Cancer of Unknown Primary	54	M	None	yes	hypernephroma-pd	NA	3n+/-, Near-triploid 69+/- (58-80)	MT	42	62.9	Mixed Cancer Types
SN12C	SN12C	Cancer of Unknown Primary	43	M	None	yes	Renal cell carcinoma-pd	NA	3n, Triploid (69)	MT	-86	29.5	Mixed Cancer Types
TK_10	TK_10	Cancer of Unknown Primary	43	M	None	yes	Renal Spindle cell carcinoma	NA	4n, Tetraploid (92)	MT	-4	51.3	Mixed Cancer Types
UO_31	UO_31	Cancer of Unknown Primary	NA	F	None	yes	Renal cell carcinoma-vpd	NA	2n+/-, Near-diploid 46+/- (35-57)	WT	59	41.7	Mixed Cancer Types

